Soliqua Solostar Injection contains the active ingredients of Insulin glargine and Lixisenatide which belong to the class of Long-Acting Insulins and Glucagon-like Peptide-1 agonists, respectively. It is used to control blood sugar levels and elevate the production of insulin in the body. It also helps to slow down glucose absorption from foods. It aids in treating type 2 diabetes in adults and controls blood sugar when it becomes abnormal. If other medicines fail to treat or control high blood glucose levels, Soliqua Solostar Injection can be given along with metformin and/or sodium-glucose co-transporter-2 (SGLT2) inhibitors. Inform your doctor if you're allergic to Insulin glargine, Lixisenatide, or any of the ingredients present in the medicine. Consult your healthcare provider if you have type 1 diabetes mellitus, diabetic ketoacidosis, heart problems, pancreatitis, and stomach or gut problems. Inform your doctor if you have a severe kidney disorder or are under dialysis treatment. It is recommended to speak with your doctor and monitor your blood sugar level before using the medicine. Inform your doctor if you are an elderly patient or have a kidney or liver problem, which will help them to adjust the dose accordingly. The safety and efficacy of the medicine in children and adolescents under 18 years of age have not been established.